MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 492 participants.

Also called NCT05908331

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 492 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05908331
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05908331. Randomized; double masking; primary purpose treatment. Start 2024-04-16 (actual); primary completion 2025-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
Acronym
MAGICAL ISR
Condition
In-Stent Restenosis
Condition
Cardiovascular Diseases
Intervention (Device)
Sirolimus Drug Coated Balloon
Intervention (Device)
Plan balloon Angioplasty (POBA)
Lead sponsor
Concept Medical Inc. (class: industry)
Collaborator
Cardiovascular Research Foundation, New York (class: other)

Record details

Record id
cardio:ct-nct05908331
Content hash
9858eeec763a4485252f8f60c17c68b78ee16846305ae97cff6fc1a4d421d11c